drug
MEROPENEM
Marketedupdated 6mo agoby Savior Lifetec Corp
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval38 co-mentions · 19 sources
- drugMeropenem HQ21 co-mentions · 21 sources
- drug(meropenem + vaborbactam)6 co-mentions · 6 sources
- companySavior Lifetec Corp4 co-mentions · 4 sources
- companyACS Dobfar SpA4 co-mentions · 4 sources
- drugpolymyxin B1 co-mentions · 1 sources
- tagRecall1 co-mentions · 1 sources
- company$TMOTHERMO FISHER SCIENTIFIC INC.1 co-mentions · 1 sources
all catalysts(10)
approval · 10
Apr 19, 2016
approval
MEROPENEM — FDA approval
MEROPENEM
→
Jun 9, 2016
approval
MEROPENEM — FDA approval
MEROPENEM
→
Sep 6, 2019
approval
MEROPENEM — FDA approval
MEROPENEM
→
Jul 22, 2024
approval
MEROPENEM — FDA approval
MEROPENEM
→
Oct 1, 2025
approval
MEROPENEM — FDA approval
MEROPENEM
→
Oct 1, 2025
approval
MEROPENEM — FDA approval
MEROPENEM
→
Feb 17, 2026
approval
MEROPENEM — FDA approval
MEROPENEM
→
Mar 11, 2026
approval
MEROPENEM — FDA approval
MEROPENEM
→
Mar 11, 2026
approval
MEROPENEM — FDA approval
MEROPENEM
→
Mar 11, 2026
approval
MEROPENEM — FDA approval
MEROPENEM
→
Trials studying MEROPENEM
- phase2A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
- phase2A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections
- phase2Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
- phase2PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
- phase3A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
- phase3Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
- phase2A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
- phase1Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that